Ascendia

  MARKET NEWS

CordenPharma & pHLIP Announce Strategic Alliance to Develop pHLIP LNP Targeted Delivery Platform for RNA & Gene Therapies
Rhythm Pharmaceuticals & LG Chem Life Sciences Enter Agreement for Rhythm to Acquire Global Rights to Oral MC4R Agonist LB54640
Boehringer Ingelheim Licenses Multiple Dark Antigens From Enara Bio to Develop Off-the-Shelf Immunotherapies for Non-Small Cell Lung Cancer
Avenue Therapeutics Reaches Final Agreement with the FDA for Phase 3 Safety Study for IV Tramadol
Silo Pharma Successfully Completes First Phase of Dose-Ranging Study of SPC-15 an Intranasal Treatment for PTSD
OBI Pharma Announces US FDA Clearance of IND Application for a Phase 1/2 Study of OBI-992

  FEATURED EDITORIAL

  COMPANY PROFILE

Windgap Medical offers drug delivery devices that simplify, automate, and accelerate the administration of complex injectables. With our patient-centric design approach, our products are designed to manage the challenges of reconstitution, liquid/liquid mixing, and sequential delivery of multiple liquid drugs.  By reducing the number of user steps, our products fit easily into a patients’ daily life, enhancing usability and adherence. You focus on the formulation. We’ll deliver the solution. Click here for more.

  EXCLUSIVE ONLINE CONTENT

Sitryx Announces Collaboration Partner Lilly Has Commenced Phase 1 Study of SIT-011 for Chronic Autoimmune & Inflammatory Diseases

Sitryx Announces Collaboration Partner Lilly Has Commenced Phase 1 Study of SIT-011 for Chronic Autoimmune & Inflammatory Diseases

Sitryx Therapeutics recently announced Eli Lilly & Company has commenced a Phase 1 first-in-human study of SIT-011, a post-translational modification modulator program for chronic autoimmune and….

Gerresheimer & Aptar Digital Health Collaborate to Develop Integrated Solution for Cancer Therapy

Gerresheimer & Aptar Digital Health Collaborate to Develop Integrated Solution for Cancer Therapy

Gerresheimer and Aptar Digital Health recently announced they will collaborate to develop an integrated solution for cancer therapy management. As part of this collaboration….

BriaCell Images Confirm Robust Anti-Tumor Activity in Patient with “Eye-Bulging” Metastatic Breast Cancer

BriaCell Images Confirm Robust Anti-Tumor Activity in Patient with “Eye-Bulging” Metastatic Breast Cancer

BriaCell Therapeutics Corp. recently released transformational images of the recently reported remarkable responder in the Phase 2 study of BriaCell’s Bria-IMT combination regimen…..

Elektrofi & Janssen Biotech Enter Worldwide Collaboration & License Agreement to Exclusively Develop Up to Five Programs Utilizing Elektrofi’s Formulation Technology

Elektrofi & Janssen Biotech Enter Worldwide Collaboration & License Agreement to Exclusively Develop Up to Five Programs Utilizing Elektrofi’s Formulation Technology

Elektrofi, Inc. recently announced it has entered a multi-target worldwide research collaboration and license agreement with Janssen Biotech, Inc. (Janssen), a Johnson & Johnson company. This collaboration will initially focus on developing an at home….

Ampersand Biomedicines Acquires AbCheck to Accelerate Platform and Product Development

Ampersand Biomedicines Acquires AbCheck to Accelerate Platform and Product Development

Acquisition amplifies Ampersand’s in-house capabilities to generate AND-Body Therapeutics – programmed biologics across a broad range of diseases….

  WHITEPAPERS & WEBINARS

WEBINAR - 2024 Trends in Topical Drug Delivery: Insights & Innovation

WEBINAR - 2024 Trends in Topical Drug Delivery: Insights & Innovation

This webinar will discuss some of the key trends from these leaders in the topical market on both a global and regional level, including the increased importance of sensory properties and the rise in non-conventional product formats, among others…..

WEBINAR - Enabling Upstream Intensified Bioprocessing

WEBINAR - Enabling Upstream Intensified Bioprocessing

Intensified upstream bioprocesses are being developed to increase productivity while reducing footprint, costs, and timelines for manufacturing. The higher cell densities generated by….

WEBINAR - Nanoparticle Suspensions: History, Applications & CMC Aspects

WEBINAR - Nanoparticle Suspensions: History, Applications & CMC Aspects

This webinar describes the history, CMC aspects, and potential applications of nanoparticle suspensions (NSs). This drug delivery technology should be considered for crystalline, sparingly water-soluble APIs. The presentation highlights….

  WHITEPAPERS & WEBINARS

WHITEPAPER - Minimizing API Supply Chain Risks

WHITEPAPER - Minimizing API Supply Chain Risks

By the time your API is brought to a contract manufacturing organization (CMO), you have already put extensive amounts of resources into developing it. It becomes essential that you optimize your API supply chain to be aware of potential risks

…

WHITEPAPER: Innovating Pharma Barrier Packaging for a Sustainable Future

WHITEPAPER: Innovating Pharma Barrier Packaging for a Sustainable Future

Honeywell Aclar® thermoformable film enables pharmaceutical and medical device companies to achieve their sustainability commitments.

Aclar® film not only delivers a high moisture barrier to protect medicines, but it also reduces pack size, reduces waste, and reduces carbon emissions, compared

…

WHITEPAPER - Copolymer Microstructures: Connecting Monomer Sequence Distribution With Biomedical End-Application Performance

WHITEPAPER - Copolymer Microstructures: Connecting Monomer Sequence Distribution With Biomedical End-Application Performance

By: Dr. Bahar Yeniad and Dr. Pieter van Delft

Experts in copolymer microstructures have an important role to play in selecting biomaterials that can deliver desired performance of (bio)medical products. But how does microstructure link to the rate of API …

  DRUG DEVELOPMENT DIRECT RESOURCES

Upcoming eNewsletter Features:

January 17 – Drug Delivery
January 24 – Bioavailability